Sunday 7th December
K.6. Hands-on training:
Fistula needling with US guidance
K.2. Cardiovascular morbidity in CKD
1. Treatment of hyperlipidemia: what's new?
2. Challenges in treating heart failure
K.3. Cardio-renal-metabolic syndrome
1. Guidelines: how to apply them in clinical practice?
2. The place of GLP-1 agonists in clinical practice
3. SGLT2 inhibitors: are they all the same?
Coffee break
K.1. Quality of Care and patient safety in HD Units
1. The NHS paradigm
2. The Greek national policy
3. The role of the Renal registries
4. Empowering patients to get their voice heard
Quality of Care and patient safety
Snack break
K.2. Poster session
3rd Workshop on Home therapies
K.6. Quality of life
1. Patient reported experience and outcome measures
2. Employment and social engagement
3. Assisted peritoneal dialysis
K.7. Clinical outcomes
1. Cardiovascular outcomes
2. Medication and dietary needs
3. Center expertise and the role of the Interdisciplinary team
K.8. Healthcare systems & policies
1. Systems Innovations to Increase Home Dialysis Utilization
2. International initiatives and the International Home Dialysis Consortium
3. System-Level Strategies to Improve Home Dialysis: Policy Levers and Quality Initiatives
Coffee break
Challenges & perspectives in Nephrology
K.7. Cardiovascular morbidity in CKD
1. Treatment of hyperlipidemia: what's new?
2. Challenges in the management of heart failure
3. Resistant and secondary hypertension
K.8. Cardio-renal-metabolic syndrome
1. Guidelines: how to apply them in clinical practice?
2. The place of GLP-1 agonists in clinical practice
3. SGLT2 inhibitors: are they all the same?
K.9. Clinical Nephrology
1. What 's new in the treatment of hereditary kidney diseases?
2. New treatments for IgA nephropathy
3. How do I treat the patient with IgA nephropathy?
K.10. Latest in hemodialysis
1. HIF inhibitors: their place in clinical practice
2. What's new in the treatment of hyperphosphatemia and uremic pruritus?
3. How do I treat the patient with hyperparathyroidism?
Close